Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients

NCT06648681 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Delirium - Postoperative
Cardiac Surgery
Cardiac Surgery Subjects
Orexin Antagonist
Feasibility Studies
Sleep
In-hospital Mortality

Interventions

DRUG: Lemborexant 5 mg
DRUG: Control (placebo) group

Sponsor

University of British Columbia

Collaborators

[object Object]
[object Object]
[object Object]